ASP Isotopes Inc. Common Stock Net Assets
ASP Isotopes Inc. Common Stock net assets. Based on the latest financial reports, ASP Isotopes Inc. Common Stock (ASPI) has net assets worth $274.79 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($572.05 Million) and total liabilities ($297.26 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore ASP Isotopes Inc. Common Stock annual equity growth to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $274.79 Million |
| % of Total Assets | 48.04% |
| Annual Growth Rate | 157.31% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 137.78 |
Net Assets of ASP Isotopes Inc. Common Stock (2021–2025)
Net assets of ASP Isotopes Inc. Common Stock from 2021 to 2025. This chart illustrates how ASP Isotopes Inc. Common Stock's net assets have evolved over time, based on quarterly financial data. See how leveraged is ASP Isotopes Inc. Common Stock's balance sheet to measure how much of total assets are equity-financed.
Annual Net Assets for ASP Isotopes Inc. Common Stock (2021–2025)
The table below shows the annual net assets of ASP Isotopes Inc. Common Stock from 2021 to 2025. For live market cap and overall valuation, see ASP Isotopes Inc. Common Stock stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $262.90 Million | +413.81% |
| 2024-12-31 | $51.17 Million | +171.72% |
| 2023-12-31 | $18.83 Million | +91.81% |
| 2022-12-31 | $9.82 Million | +63.69% |
| 2021-12-31 | $6.00 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to ASP Isotopes Inc. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 22865707300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
ASP Isotopes Inc. Common Stock Net Assets Breakdown (December 2025)
ASP Isotopes Inc. Common Stock net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $1.12 Million | 0.55% |
| Other Comprehensive Income | $2.54 Million | 1.25% |
| Other Components | $431.76 Million | 211.49% |
| Total Equity | $204.15 Million | 100.00% |
ASP Isotopes Inc. Common Stock Competitors by Market Cap
The table below lists competitors of ASP Isotopes Inc. Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Zhejiang Baida Precision Mnfg
SHG:603331
|
$277.50 Million |
|
Zhejiang Shapuaisi Pharmaceutical Co Ltd
SHG:603168
|
$277.56 Million |
|
Itafos Corp
V:IFOS
|
$277.58 Million |
|
MFS Intermediate Income Trust
NYSE:MIN
|
$277.67 Million |
|
Larvotto Resources Ltd
AU:LRV
|
$277.44 Million |
|
Road Environment Technology Co. Ltd. A
SHG:688156
|
$277.36 Million |
|
FSP Technology Inc
TW:3015
|
$277.29 Million |
|
TruBridge Inc.
NASDAQ:TBRG
|
$277.27 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ASP Isotopes Inc. Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 47,898,492 to 204,151,000, a change of 156,252,508 (326.2%).
- Net loss of 175,092,000 reduced equity.
- New share issuances of 320,304,000 increased equity.
- Other comprehensive income increased equity by 4,706,313.
- Other factors increased equity by 6,334,195.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-175.09 Million | -85.77% |
| Share Issuances | $320.30 Million | +156.9% |
| Other Comprehensive Income | $4.71 Million | +2.31% |
| Other Changes | $6.33 Million | +3.1% |
| Total Change | $- | 326.22% |
Book Value vs Market Value Analysis
This analysis compares ASP Isotopes Inc. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.74x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 10.37x to 0.74x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | $0.17 | $1.81 | x |
| 2022-12-31 | $0.27 | $1.81 | x |
| 2023-12-31 | $0.49 | $1.81 | x |
| 2024-12-31 | $0.86 | $1.81 | x |
| 2025-12-31 | $2.46 | $1.81 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ASP Isotopes Inc. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -85.77%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -734.17%
- • Asset Turnover: 0.05x
- • Equity Multiplier: 2.51x
- Recent ROE (-85.77%) is below the historical average (-69.41%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -43.48% | 0.00% | 0.00x | 1.19x | $-3.21 Million |
| 2022 | -50.37% | 0.00% | 0.00x | 1.27x | $-5.93 Million |
| 2023 | -99.94% | -3761.03% | 0.01x | 1.85x | $-17.92 Million |
| 2024 | -67.51% | -780.26% | 0.04x | 1.97x | $-37.12 Million |
| 2025 | -85.77% | -734.17% | 0.05x | 2.51x | $-195.51 Million |
Industry Comparison
This section compares ASP Isotopes Inc. Common Stock's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $1,402,524,921
- Average return on equity (ROE) among peers: 5.18%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ASP Isotopes Inc. Common Stock (ASPI) | $274.79 Million | -43.48% | 1.08x | $277.49 Million |
| Albemarle Corp (ALB) | $622.60 Million | 12.56% | 0.93x | $10.64 Billion |
| Alto Ingredients Inc (ALTO) | $392.81 Million | -0.04% | 0.16x | $275.36 Million |
| Aemetis Inc (AMTX) | $-9.45 Million | 0.00% | 0.00x | $83.00 Million |
| Air Products and Chemicals Inc (APD) | $4.73 Billion | 15.06% | 1.20x | $62.29 Billion |
| Ashland Global Holdings Inc (ASH) | $3.41 Billion | 0.03% | 1.53x | $3.34 Billion |
| Aspen Aerogels Inc (ASPN) | $128.41 Million | -21.71% | 0.42x | $407.47 Million |
| Avient Corp (AVNT) | $631.40 Million | 11.39% | 2.37x | $3.38 Billion |
| Axalta Coating Systems Ltd (AXTA) | $2.39 Billion | 15.80% | 2.18x | $7.02 Billion |
| Balchem Corporation (BCPC) | $331.36 Million | 13.54% | 0.14x | $5.17 Billion |
About ASP Isotopes Inc. Common Stock
ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay lo… Read more